🔗 Share this article

The top legal official in Texas Ken Paxton is suing the producers of Tylenol, asserting the corporations hid alleged dangers that the medication posed to pediatric brain development.

This legal action follows four weeks after President Donald Trump publicized an unverified association between taking acetaminophen - also known as paracetamol - during pregnancy and autism in young ones.

Paxton is filing suit against Johnson & Johnson, which previously sold the medication, the exclusive pain medication suggested for women during pregnancy, and the current manufacturer, which presently makes it.

In a statement, he said they "misled consumers by making money from pain and promoting medication without regard for the potential hazards."

The company asserts there is lacking scientific proof connecting acetaminophen to autism spectrum disorder.

"These manufacturers lied for decades, intentionally threatening millions to boost earnings," Paxton, from the Republican party, declared.

Kenvue said in a statement that it was "deeply concerned by the spread of false claims on the safety of acetaminophen and the possible consequences that could have on the well-being of women and children in America."

On its online platform, Kenvue also mentioned it had "continuously evaluated the relevant science and there is lacking reliable evidence that indicates a verified association between consuming paracetamol and autism."

Associations speaking for physicians and healthcare providers agree.

ACOG has said acetaminophen - the primary component in Tylenol - is among limited choices for expectant mothers to manage discomfort and elevated temperature, which can pose significant medical dangers if left untreated.

"In over twenty years of studies on the utilization of acetaminophen in pregnancy, zero credible investigations has conclusively proven that the usage of paracetamol in any period of gestation results in neurological conditions in children," the group said.

This legal action references latest statements from the previous government in arguing the drug is allegedly unsafe.

In recent weeks, Trump generated worry from public health officials when he told women during pregnancy to "struggle intensely" not to take Tylenol when unwell.

Federal regulators then released a statement that physicians should contemplate reducing the usage of acetaminophen, while also stating that "a causal relationship" between the medication and autism in children has not been proven.

The Health Department head Robert F Kennedy Jr, who manages the Food and Drug Administration, had pledged in spring to conduct "a massive testing and research effort" that would determine the source of autism spectrum disorder in a short period.

But experts cautioned that finding a unique factor of autism - thought by researchers to be the result of a intricate combination of genetic and external influences - would not be simple.

Autism is a category of lifelong neurodivergence and disability that impacts how individuals experience and interact with the environment, and is recognized using doctors' observations.

In his lawsuit, Paxton - who supports Trump who is seeking US Senate - alleges Kenvue and J&J "willfully ignored and attempted to silence the science" around acetaminophen and autism spectrum disorder.

This legal action attempts to require the corporations "destroy any promotional materials" that states Tylenol is reliable for pregnant women.

The court case parallels the concerns of a group of mothers and fathers of minors with autism and attention deficit hyperactivity disorder who took legal action against the makers of acetaminophen in recently.

Judicial authorities dismissed the legal action, saying studies from the family's specialists was not conclusive.